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This is more common than other conditions that are screened for, as Figure 1 demonstrates. 5 It is now generally accepted that the first 36 months of life are a critical period for the acquisition of language skills, with much conditioning taking place in the first 6 months. Failure to detect hearing impairment in this period and thus, failure to provide appropriate intervention, results in impaired language development and a reduced ability to socially interact, as well as low academic achievement and the need for expensive specialist educational support. Once this period has passed, the opportunity to develop normal spoken language has been lost, leaving sign language as the remaining preferred method of communication. Sign language has the obvious limitation of requiring the``listener'' to be conversant with it also.
Yoshinaga-Itano and coworkers examined the language quotient (LQ) of children with an identified hearing loss detected at either pre or post 6 months of age. 6 The LQ for a child with normal language for their age is 100. In children with normal cognitive function, those with hearing loss detected before 6 months of age had an LQ of 91.3 (standard deviation 19.8) as compared with those who were later detected, who had an LQ of just 70.2 (standard deviation 18.5). This suggests that early identification of hearing loss results in near-normal development of language skills.
OBJECTIVE:
To investigate the implications of technology choice between automated auditory brainstem response ( AABR ) and transiently evoked otoacoustic emissions ( TEOAE ) on service provision for a universal newborn hearing screening ( UNHS ) program.
METHOD:
Over a 4 -day period, we offered to perform AABR hearing screening on a cohort of 48 well babies in the maternity unit and outpatient department of our busy district hospital. Those parents that consented were asked to sign a consent form and their babies were then screened using the Natus ALGO Model 2e color newborn hearing screener supplied on loan from Neonatal Perspectives Ltd, Manchester, UK. We recorded the patient age at testing, test duration, results obtained ( as a pass / refer ) and any problems that we experienced with the screening progress, together with parent or user perceived differences between this technology and the current TEOAE screen. A single user carried out all screening. Having collected the AABR data, we then analyzed the implications of the results in relation to service provision in our hospital, utilizing historical data on TEOAE screening.
RESULTS:
Forty -four mothers, from 48, consented to having their baby screened by AABR and we were able to achieve a result in all 44 babies that we screened. At the standard test criteria of 35 dBnHL, a total 42 babies passed the initial screen in both ears and 2 referred in a single ear only. The test duration was less than 5 minutes for 36 of 44 babies. Applying these results to a model of UNHS generated a per screen cost of £15.98 for a two -stage OAE / AABR program and £14.25 for an AABR -only program. Parents found the AABR test acceptable and we found that being able to discuss the screen and hearing with the parents while the screen was taking place both timeefficient and reassuring to parents. In our experience and using our screening model, the OAE / AABR two -stage approach would have generated 509 infants for second -stage screening ( AABR stage ) before full Infant Hearing Impairment and Universal Hearing Screening
Currently, universal screening is conducted by health visitors throughout the UK, with some exceptions, at around 9 months of age using the distraction test method. Although this is one of the few methods of screening that tests the whole auditory pathway, sensitivity is low and certain``at-risk'' groups such as mentally handicapped patients are not easily tested. 7 More importantly, the test does not allow the opportunity to intervene in the critically important period of the first year of life.
To offer the best opportunity for early intervention, universal newborn hearing screening (UNHS) is clearly warranted. Despite lagging behind the US, Europe has made substantial progress toward adoption of UNHS, with cross-European collaboration generating scientific and clinical agreement. 8 Many maternity units around the UK, including our own, are now considering how best to achieve UNHS and the implications that implementation of universal testing brings. In a well-organized program, consideration must be given to the screening itself, the management of referrals, diagnosis and availability of intervention, as well as correct staffing provision for all of these elements. Given the marked differences between technology types used for screening, we conducted a formal evaluation of the Natus ALGO Model 2e color newborn hearing screener to investigate its suitability in our particular clinical setting.
METHODS
Over a period of 4 days commencing 31st January 2000, in York District Hospital, all mothers on the maternity wards, as well as those attending with infants for outpatient newborn screening, were offered a hearing assessment for their infants. Parents where given an information sheet clearly explaining why we wished to screen, what the screening involved, what would happen to the results. Parents were encouraged to remain with their child for the screen and were reassured that at no time would the child be moved elsewhere for the purpose of screening. If parents agreed, they were asked to sign a consent form, with the mother's signature as a minimum.
Screening took place between the hours of 8 AM and 5 PM, by a single senior audiologist (K. I.) when the babies were settled, ideally asleep. Inpatient babies were screened at the mother's bedside in the baby's own crib. Babies were not placed in a quiet room. Outpatient babies were screened in Department of Audiology quiet rooms.
Screening was conducted using the default screen (right/left ear simultaneous screen at 35 dBnHL) of the Natus ALGO Model 2e color newborn hearing screener (ALGO screener) that had been provided by Neonatal Perspectives Ltd, Manchester, UK. Before commencement of the evaluation period, Neonatal Perspectives Ltd staff provided training of approximately 1 hour. Before this, all screening had been conducted using transiently evoked otoacoustic emissions (TEOAE) measured on the ILO88 from Otodynamics, run in Quickscreen Mode. The Natus ALGO and Otodynamics ILO88 equipment remain the most commonly used screening methodologies in both the UK and the US.
The ALGO screener is a laptop-driven automated device for measuring brainstem auditory evoked responses. It works by delivering a 35-dB click (the click consists of frequencies across 700 to 5000 Hz) into special pre-gelled, disposable earphones that are shielded to reduce ambient noise interference. The waveform generated from the brainstem is recorded in raw form through three button electrodes and compared with a template derived from normally hearing infants between 34 weeks gestation and 6 months of age. The waveform must comply with the template at nine separate, predefined points for the screener to register a match. The ALGO screener software program logs matches to the repeated clicks and automatically grants a pass when it receives sufficient matches to achieve a minimum statistical confidence of 99.98% that the signals received result from the clicks delivered. At this point it will`p ass'' that ear. If the screener does not reach the required level of statistical confidence after 15,000``sweeps'' in a particular ear then it`r efers'' that ear. The result is recorded in the screener database, displayed on screen and automatically printed onto a nonthermal sticker for notes.
The screener is set up in three stages, patient information, selection of screening method, and attachment to the baby. When the screener is switched on it boots to a main switchboard. A single keystroke brings up the patient-information screen, into which to the baby preparation screen, on which you find step-by-step instructions. Button electrodes are placed on the upper forehead below the hairline, the nape, and the shoulder. Impedance is required to be below 12 k and this is monitored on screen. Skin preparation or cleansing is generally not necessary. The disposable earphones are placed over the ears, with the acoustic cable end already mounted into them. Nothing is placed in the infant's ears. After data acquisition, the mothers were immediately informed of the results. Results were recorded in the infant's Child Health Record (red health book) and a letter sent informing the general practitioner. The infant's health visitor was also informed and each was asked to forward the results of the distraction test when available, for later follow up.
RESULTS
A total of 48 mothers were offered an assessment of their baby's hearing status. Of those, 44 were consented and screening conducted. Two mothers declined the assessment, citing that they did not feel it was important enough, a further one agreed but mother and baby were discharged before the test could take place and the last was keen to have the test but mother was unwell during her stay and has agreed to return for outpatient testing. Of those babies screened, 28 were boys. In-patient screening was conducted on 36 of the 44 babies.
Age at screening is shown in Tables 1 and 2 . Of those screened as in-patients, 14% were screened on the first day of life, and 56% on day 1 or 2. Only 11% were screened beyond day 4. All of the outpatient screens were conducted between 1 and 12 weeks of age.
The ALGO screener records the duration of screening automatically and we banded the results. These are shown in Table  3 . A total of 45 test times were recorded, allowing for a single baby that we re-tested on slightly less stringent criteria. The total test time including discussion with parents, set up of screener and baby, and conducting the screen was approximately 15 minutes. No screen had to be aborted.
Of those babies tested, 42 passed in both ears, with 2 babies referring in a single ear, one on the left ear and one on the right ear.
One of the two refers was re-tested immediately on 70/40-dBnHL mode and a pass obtained at 40 dB. The second refer was appointed for diagnostic ABR and subsequently found to hear at the 40-dB level. Given that the ALGO screener is designed to conduct an initial screen at 35 dB, it correctly identified the two infants with mild hearing loss outside that range, although these would not have been classed as referrals when using the current proposed screening guidelines of bilateral refer at 40 dB in the better ear. So, using the ALGO screener's own criteria, we generated a by-ear referral rate of 2.3% after a single screen and using the current proposed guidelines requiring a bilateral refer, we did not generate a refer at all, despite conducting 14% of tests on the first day of life.
Practical similarities and differences between automated auditory brainstem response (AABR) and our existing TEOAE test were recorded. The AABR test could be conducted without the need for a quiet environment, whereas it is difficult to achieve an OAE response with elevated ambient noise levels. This allowed us to talk through the procedure while the screen was in progress, a factor that the parents found reassuring. The overall duration of the screening process was similar to our previous experiences with OAE.
DISCUSSION
UNHS has the potential to identify many infants requiring follow-up to assess their true hearing status. The implications of this have to be considered in light of service provision.
York District Hospital has around 3200 births per annum. Our current program of targeted screening, the majority of which is well babies with a family history, uses TEOAE conducted on the ILO88 from Otodynamics, run in Quickscreen Mode. This generates an initial refer of some 20%. If this were rolled out to all 3200 births then we could expect to conduct as many as 640 second-stage tests, the majority of which would be as outpatient appointments. This has serious staffing considerations, as well as the less tangible issue of parental anxiety associated with the wait from initial screen to confirmation of hearing status.
Current proposed guidelines for screening in the UK suggest that the standard first screen should be OAE, followed by AABR for those that refer at this first stage. AABR should also be adopted for those infants expected to be discharged early (representing some 14% of infants in York) and all at-risk infants (representing about 10% of all births). A recent study looking at referral rates of 110 infants tested with either OAE or AABR in the first 24 hours, using the ILO88 in Quickscreen Mode or the Natus ALGO This supports the use of AABR in the first 24 hours.
We have examined three models of UNHS from both a time and cost perspective, the first being the proposed guidelines and the second being a totally AABR program. We have assumed the cost of disposables for the ALGO screener to be around £4.75 and for the ILO88 around £1.00. We have assumed the average total duration of screen to be 15 minutes for both technologies. We have assumed a 10% high-risk group, 14% short discharge, and the remainder as normal discharge well babies. We have made referral rate assumptions based on our own experience and that of recently published studies in a similar setting. Screening disposables cost is assumed at £1.00 per screen for OAE and £4.75 per screen for AABR and is reflective of current charges. We have assumed first-stage referral rates for OAE of 20% in``at-risk'' babies, 37% in``shortdischarge'' babies, and 20% in``well'' babies. We have assumed referral rates for first-stage AABR of 3% for both at-risk and shortdischarge babies and 2% for well babies. Table 4 depicts the cost analysis of a two-step/two-technology program. The total screening hours in our two-step model would be 927.25 and our total disposables cost would be £8,499. In addition, we would have a follow-up administration burden of 509 infants from the first-stage screen. Table 5 depicts the cost analysis of an AABR-only model. The total screening hours in our AABR-only model would be 872 and our total disposables cost would be £15,543. In addition, we would have a follow-up administration burden of 72 infants from the first-stage screen.
We assumed that a screening hour costs around £35.00, including personnel, personnel administration, and facilities costs, and that the administration of follow-up takes around 1 hour per referred baby for appointments, clinic letters, GP letters, and notes retrieval, at an administration hour cost of around £20.00, including personnel, personnel administration, and facilities costs. We then calculated the cost per program outright, as indicated in Table 6 .
It is clear that the ALGO screener requires a greater outlay in disposables, but results in a much-reduced initial referral rate. The low referral rate is confirmed by other authors.
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The resulting cost savings throughout the trust would be greater than the extra cost of the disposables. When we look at the single greatest increase in costs, it is the administrative burden of arranging and managing the second-stage screens (£10,180). Introducing a further OAE stage in an attempt to reduce disposables cost would actually increase this and is thus counter intuitive. Attempting to conduct AABR immediately after an OAE refer doubles the first-stage total screening time, and this would require much greater 24-hour staffing provision in the attempt to get the screening conducted before discharge. What is perhaps more critical is that the initial referral rate following OAE would require additional audiology staff for the second-stage testing whereas the lower initial referral rate with AABR, around three per fortnight, is manageable within existing audiology staffing.
There are further technological differences that need consideration when adopting a screening method. These include equipment falsenegative rates, screening environment, parental anxiety, and training.
Current guidelines proposals do not make recommendations on false-negative rates, the number of infants with a hearing loss that pass a particular screen. However, it is a primary requirement of a OAE works by measuring the acoustic signal created by vibration of the tympanic membrane in response to mechanical energy within the cochlea that has resulted from outer-hair-cell movement. 13 A microphone placed within the outer ear measures this acoustic signal. It is well known that otoacoustic emissions cannot be generated when the outer hair cells are damaged or nonfunctional and it is here that OAE plays a role in differential diagnosis. OAE only deals with middle-and outer-ear problems, as far as the outer hair cells of the cochlea. Infants with a nonorganic hearing loss or hearing loss that involves the neural hearing pathway can generate a normal OAE and thus be``passed'' as having normal hearing when in fact they could have a profound loss. 14, 15 There is very little data on incidence of retrocochlear hearing loss and until the incidence is better defined, AABR (which derives signal from the brainstem directly) would seem a more complete screen.
Currently, our screening is conducted either at the bedside or in clinic, in an acoustically controlled environment. We do not have the facility to screen large numbers of babies in quiet rooms within our maternity environment. The cost of providing quiet rooms would be immense and unnecessary. Furthermore, it becomes ever less acceptable to remove a baby from the mother. Cot-side OAE measurement is reliant on keeping ambient noise at a low level. Screening in the normal hospital environment without ambient noise controls increases the referral rate, consequently decreasing the sensitivity and specificity. 16 Controlling ambient noise precludes concurrent explanation to the parents of what is happening and the ability to reassure parents at a particularly sensitive time. Furthermore, it can restrict the selection of screening opportunity to smaller time windows, making it more difficult to achieve predischarge screening.
UNHS is likely to be one of the first tests an infant receives. Screening at this sensitive stage is likely to raise parental anxiety. The AAP calls for a maximum initial referral rate of 4% with a falsepositive rate of less than 3%. 12 An increased referral of normally hearing babies is likely to have a significant and adverse effect on parental anxiety. Keeping the initial referral rate as low as possible, without compromising sensitivity, should be a primary goal.
Currently, trained audiologists conduct all our OAE testing. It is generally accepted that operators need considerable training and practice to achieve consistent OAE results. We achieve an initial referral rate of around 20%. With just 1 hour's training on the ALGO screener we reduced our initial referral rate to just 2% (zero by the current proposed guidelines), albeit within the limitation of small numbers. Appropriate service provision must be made for initially higher referral rates with OAE. The simplicity of the ALGO screener allows consistent results from the outset. Furthermore, the less invasive screening methodology allows the screener to be used reliably by a variety of nontechnical staff, such as nursery nurses and auxiliaries. In our clinical setting this will greatly improve 24-hour access to screening and increase the amount of screening conducted before discharge.
CONCLUSIONS
Individual hospitals must fully evaluate the implications of implementation of UNHS in relation to their own circumstances. Currently, there is insufficient data on the use of different technologies in a real-life setting. We found that in the busy district hospital setting, a program adopting TEOAE as the primary screen would be more expensive than one using AABR as the initial screen. Furthermore, we found that in our hands, OAE generates a higher than desirable rate of referral with serious implications for both follow-up administration and parental anxiety.
In contrast, with minimal training, we found AABR to generate a low initial referral. Although our numbers are small, the low referral rate was seen across all infants, including those discharged within the first 24 hours. The equipment was easy to use and will allow us to use more appropriate staffing grades for the initial screen. Furthermore, the low initial referral rate would not have an impact on our existing audiological services. The implications of early identification of hearing loss, and the consequential need to provide intervention have not been examined in this study. 
